Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial
Premium

Premium: US FDA Warning Letter to Sun Pharmaceutical Industries for Halol facility

 

On the 17-Dec-15 (Thursday), the US FDA issued a Warning Letter to Sun Pharmaceuticals. The letter was in relation to the inspection performed from 8-19 September, 2014, at the Pharmaceutical manufacturing facility, Halol-Baroda Highway, Halol, Gujarat.

Sun Pharmaceuticals confirmed the receipt of the US FDA Warning Letter on the 19-Dec-15 (Saturday) - after the markets had closed for the week. (refer here for the Original Copy

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial